Identification and Audit Response of Financial Fraud in Listed Companies in Pharmaceutical Industry

Yanan Li
DOI: https://doi.org/10.54097/fbem.v7i2.4353
2023-02-05
Abstract:Financial fraud is the conscious misstatement and neglect of financial information by enterprises, which is often difficult to be detected due to the asymmetric nature of information. In recent years, frequent lightning in the capital market, especially the high incidence of financial fraud in listed companies in the pharmaceutical industry, has greatly jeopardized the market order. Therefore, the article discusses the common fraudulent means and differences that the two companies have in conjunction with the financial reports and related announcement information of Kangmei Pharmaceutical and Kangdexin, dissects the abnormal characteristics of identifying financial fraud risks, and proposes corresponding audit response ideas and methods to safeguard the capital market order and investors' interests.
What problem does this paper attempt to address?